Glycogen synthase kinase (GSK) 3beta hyperactivity impairs glomerular podocyte insulin signaling via IRS1 modulation in diabetic kidney disease

Authors

  • Mengxuan Chen The University of Toledo Department of Medicine
  • Yan Ge Division of Nephrology, University of Toledo College of Medicine
  • Lance Dworkin Division of Nephrology, University of Toledo College of Medicine https://orcid.org/0000-0002-2471-5989
  • Rujun Gong Division of Nephrology, University of Toledo College of Medicine

DOI:

https://doi.org/10.46570/utjms-2025-1352

Keywords:

GSK3beta hyperactivity, hyperinsulinemia, diabetic kidney disease

Downloads

Published

2025-06-30

How to Cite

Chen, M., Ge, Y., Dworkin, L., & Gong, R. (2025). Glycogen synthase kinase (GSK) 3beta hyperactivity impairs glomerular podocyte insulin signaling via IRS1 modulation in diabetic kidney disease. Translation: The University of Toledo Journal of Medical Sciences, 13(S3). https://doi.org/10.46570/utjms-2025-1352

Issue

Section

Dr. Lance D. Dworkin Department of Medicine Research Symposium